Improving Outpatient Antimicrobial Stewardship: Taking the Next Step
In the August Editor-in-Chief's Letter, Dr. Jason Gallagher discusses how we can improve outpatient antimicrobial stewardship.
Read More
Two Allergies or Cross-Reactive?
The story of penicillin and cefazolin.
A Case of CNS Nocardia farcinica Presenting as Aphasia in an Immunocompetent Host
Quick recognition is key to early initiation of treatment and long-term survival.
Antiretroviral Safety in Pregnancy: Focus on Dolutegravir, Integrase Inhibitors, and Neural Tube Defects
There has been increasing interest in the association between neural tube defects, dolutegravir, and integrase inhibitors as a class since 4 cases were reported in 2018.
The Continued Search for Optimal Daptomycin Dosing Strategies in VRE Bloodstream Infections
Optimal dosing of daptomycin is unknown, but study results suggest higher doses are required for successful clinical and microbiological outcomes.
Maximize Contact and Minimize Isolation
Optimizing the relationship between infection prevention and antimicrobial stewardship.
2019: Measles Outbreaks in the United States
An update for clinical providers.
Doravirine: Researchers DRIVE for a Drug Ahead of Its Class
A novel NNRTI hits the market, but what place will it have in treatment?
Does Decreased Renal Function Predict Worse Outcomes With Newer Antimicrobials?
Numerous studies need to be performed to ensure adequate antimicrobial dosing, partic­ularly in the setting of renal impairment and critical illness.
Postulates About the Prostate: Fosfomycin for Chronic Bacterial Prostatitis
Fosfomycin is an attractive potential option because it does not cross-react with other antimicrobials, making it a good choice in patients with extensive drug allergies.
